D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Enpro
NPO
$6.95B
| $674K | ﹤0.01% |
7,896
-9,115
| -54% | -$744K |
|
3227
Rhythm Pharmaceuticals
RYTM
$7.28B
| $673K | ﹤0.01% |
+31,653
| New | +$918K |
|
3228
AZZ Inc
AZZ
$4.47B
| $672K | ﹤0.01% |
13,339
-5,380
| -29% | -$272K |
|
3229
Innospec
IOSP
$2.11B
| $672K | ﹤0.01% |
6,547
-11,556
| -64% | -$1.14M |
|
3230
Columbia Financial
CLBK
$1.13B
| $668K | ﹤0.01% |
+38,197
| New | +$634K |
|
3231
Westwood Holdings Group
WHG
$186M
| $667K | ﹤0.01% |
46,099
-9,054
| -16% | -$139K |
|
|
ALLK
3232
CALL
DELISTED
Allakos
ALLK
| $666K | ﹤0.01% |
5,800
-10,000
| -63% | -$1.26M |
|
3233
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $664K | ﹤0.01% |
+10,000
| New | +$660K |
|
3234
PUT
Arrowhead Research
ARWR
$12B
| $663K | ﹤0.01% |
10,000
| – | – |
|
3235
PUT
Under Armour
UAA
$3.02B
| $663K | ﹤0.01% |
29,900
-170,100
| -85% | -$3.55M |
|
|
CADE
3236
DELISTED
Cadence Bancorporation
CADE
| $662K | ﹤0.01% |
+31,944
| New | +$650K |
|
|
ELVT
3237
DELISTED
Elevate Credit, Inc.
ELVT
| $659K | ﹤0.01% |
225,834
-54,732
| -20% | -$228K |
|
3238
Dorian LPG
LPG
$1.88B
| $658K | ﹤0.01% |
+50,151
| New | +$666K |
|
3239
Astec Industries
ASTE
$1.29B
| $655K | ﹤0.01% |
8,687
-5,885
| -40% | -$399K |
|
3240
Jacobs Solutions
J
$16B
| $655K | ﹤0.01% |
6,127
-13,759
| -69% | -$1.31M |
|
3241
Illinois Tool Works
ITW
$81.9B
| $652K | ﹤0.01% |
2,944
-261,582
| -99% | -$54.3M |
|
3242
HBT Financial
HBT
$1.26B
| $647K | ﹤0.01% |
37,755
-3,913
| -9% | -$63.5K |
|
|
OCAXU
3243
DELISTED
OCA Acquisition Corp. Unit
OCAXU
| $645K | ﹤0.01% |
+64,568
| New | +$663K |
|
3244
Brady Corp
BRC
$4.54B
| $644K | ﹤0.01% |
12,043
-40,578
| -77% | -$2.12M |
|
|
ENJY
3245
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $641K | ﹤0.01% |
+64,835
| New | +$669K |
|
3246
Pan American Silver
PAAS
$18.6B
| $639K | ﹤0.01% |
21,285
-58,889
| -73% | -$1.91M |
|
|
BERY
3247
DELISTED
Berry Global Group, Inc.
BERY
| $639K | ﹤0.01% |
+11,333
| New | +$588K |
|
|
WPRT
3248
Westport Fuel Systems
WPRT
$33.4M
| $638K | ﹤0.01% |
+8,860
| New | +$749K |
|
3249
AGCO
AGCO
$8.71B
| $635K | ﹤0.01% |
4,417
-84,380
| -95% | -$10.5M |
|
3250
Cabot Corp
CBT
$4.61B
| $635K | ﹤0.01% |
12,109
-28,466
| -70% | -$1.4M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.